Guides & Resources
News
Ivermectin + Mebendazole in Cancer Care: New Re...
A first-of-its-kind observational report involving 197 cancer patients found that the combination of ivermectin and mebendazole was associated with an 84% clinical benefit ratio, including tumor regression or disease stabilization...
Ivermectin + Mebendazole in Cancer Care: New Re...
A first-of-its-kind observational report involving 197 cancer patients found that the combination of ivermectin and mebendazole was associated with an 84% clinical benefit ratio, including tumor regression or disease stabilization...
Mebendazole for Cancer: Mechanisms, Research, a...
Mebendazole is an FDA-approved antiparasitic drug being studied in cancer research for its ability to disrupt microtubules, inhibit tumor cell division, and affect metabolic pathways. While promising in preclinical and...
Mebendazole for Cancer: Mechanisms, Research, a...
Mebendazole is an FDA-approved antiparasitic drug being studied in cancer research for its ability to disrupt microtubules, inhibit tumor cell division, and affect metabolic pathways. While promising in preclinical and...
Why Most Parasite Cleanses Fail: The Missing Ha...
Most parasite cleanses fail because they target only one category of parasites—either helminths (worms) or protozoa—while ignoring the other. Since these organisms differ biologically and require different mechanisms to address,...
Why Most Parasite Cleanses Fail: The Missing Ha...
Most parasite cleanses fail because they target only one category of parasites—either helminths (worms) or protozoa—while ignoring the other. Since these organisms differ biologically and require different mechanisms to address,...
Mebendazole Dosage Guide: What Research and Stu...
Mebendazole dosage in cancer research is actively being studied through clinical trials and experimental protocols, with dosing strategies ranging from standard antiparasitic use to higher sustained regimens. Researchers are investigating...
Mebendazole Dosage Guide: What Research and Stu...
Mebendazole dosage in cancer research is actively being studied through clinical trials and experimental protocols, with dosing strategies ranging from standard antiparasitic use to higher sustained regimens. Researchers are investigating...
Ivermectin vs Mebendazole vs Fenbendazole for C...
Research, Protocols, Mechanisms, and Future Treatment Potential Interest in repurposed antiparasitic drugs for cancer has expanded rapidly in recent years, driven by a deeper understanding of cancer as a complex,...
Ivermectin vs Mebendazole vs Fenbendazole for C...
Research, Protocols, Mechanisms, and Future Treatment Potential Interest in repurposed antiparasitic drugs for cancer has expanded rapidly in recent years, driven by a deeper understanding of cancer as a complex,...
ISOM Protocol Explained: Metabolic Cancer Strat...
The ISOM Protocol is a metabolic cancer framework that targets cancer cell energy production using repurposed drugs, nutritional therapy, and lifestyle interventions. It focuses on disrupting glucose and glutamine metabolism...
ISOM Protocol Explained: Metabolic Cancer Strat...
The ISOM Protocol is a metabolic cancer framework that targets cancer cell energy production using repurposed drugs, nutritional therapy, and lifestyle interventions. It focuses on disrupting glucose and glutamine metabolism...
Ivermectin + Mebendazole in Cancer Care: New Report Shows 84% Clinical Benefit
A first-of-its-kind observational report involving 197 cancer patients found that the combination of ivermectin and mebendazole was associated with...
Demodex Mites in Humans: Clinical Evidence, Rosacea & Ivermectin Research
Demodex mites are microscopic organisms naturally present on human skin, typically living within hair follicles and sebaceous glands. While usually...
Mebendazole for Cancer: Mechanisms, Research, and Why It’s Often Combined with Ivermectin
Mebendazole is an FDA-approved antiparasitic drug being studied in cancer research for its ability to disrupt microtubules, inhibit tumor cell divi...
Why Most Parasite Cleanses Fail: The Missing Half Doctors Rarely Explain (Worms vs Protozoa)
Most parasite cleanses fail because they target only one category of parasites—either helminths (worms) or protozoa—while ignoring the other. Since...
Ivermectin Dosage Guide: What Research and Clinical Trials Suggest
Ivermectin dosage in cancer research varies from standard antiparasitic use to experimental cyclical dosing strategies explored in clinical trials....
Mebendazole Dosage Guide: What Research and Studies Say
Mebendazole dosage in cancer research is actively being studied through clinical trials and experimental protocols, with dosing strategies ranging ...
